Physician profile
Nicholas Andre Howard
NPI 1083051759
$880.52
in general payments reported to CMS, 2019-2025
11 companies · $94.50 in 2025
The $94.50 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.76 · 2020: $109 · 2021: $86.43 · 2022: $170 · 2023: $157 · 2024: $177 · 2025: $94.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $428.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $183.38 | 2024-2025 | |
| Pfizer INC. | $180.20 | 2020-2023 | |
| Merck Sharp & Dohme LLC | $140.50 | 2020-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Pacira Pharmaceuticals Incorporated | $132.97 | 2022 | |
| Glaxosmithkline, LLC. | $83.16 | 2019-2020 | |
| Cranial Technologies, INC | $57.64 | 2020-2025 | Doc Band |
| Alexion Pharmaceuticals, INC. | $28.05 | 2019 | |
| Seqirus USA INC | $22.71 | 2025 | Flucelvax |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.72 | 2019 | |
| Kaleo, INC. | $19.56 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $11.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.